Background Radiofrequency catheter ablation requires precise positioning of the ablation electrode. Fluoroscopically guided catheter manipulation has limitations, and there are risks of radiation exposure. The purpose of this study was to examine the feasibility of guiding catheter ablation within the right atrium with catheter-based intracardiac echocardiography.
Radiofrequency Catheter Ablation Guided by Intracardiac Echocardiography
Edward Chu, MD; Adam P. Fitzpatrick, MD; Michael C. Chin, BS; Krishnankutty Sudhir, MD, PhD; Paul G. Yock, MD; Michael D. Lesh, MD Background Radiofrequency catheter ablation requires precise positioning of the ablation electrode. Fluoroscopically guided catheter manipulation has limitations, and there are risks of radiation exposure. The purpose of this study was to examine the feasibility of guiding catheter ablation within the right atrium with catheter-based intracardiac echocardiography.
Methods and Results A 10F, 10-MHz intracardiac imaging catheter was used to direct an ablation electrode at four or five anatomic landmarks in the right atrium. Thirty-eight radiofrequency energy applications were performed in nine anesthetized dogs, and 38 lesions were identified on pathological examination. Lesions were created a mean of 1.9±2.1 mm from the ultrasound-guided site. Twenty-six of 38 lesions (68%) were less than 2.2 mm from the imaged site. Intracardiac echocardiography also was used to confirm stable electrode-endocardial contact in 37 energy applications (97%) and identified catheter movement in 9 energy applications (24%).
Discrete lesions, microcavitations, and thrombi were observed in 13 (34%), 23 (61%), and 19 (50%) of 38 energy applications, respectively. Microcavitations predicted the appearance of thrombus. Fluoroscopy time required to create four or five lesions decreased from 23 minutes in the first study to less than 2 minutes in the last five studies.
Conclusions Catheter-based intracardiac echocardiography can accurately guide catheter ablation directed at anatomic landmarks and potentially reduce ionizing radiation exposure. Intracardiac imaging can be used to confirm endocardial contact, identify electrode movement, and directly visualize lesions. Intracardiac echocardiography also can be used to identify microcavitations, which predict thrombus formation during radiofrequency energy applications. endocardial contact and lesion formation6.7; however, ICE has not been validated as an accurate guide to anatomically based lesion placement.
The purpose of this study was to test the hypothesis that ICE can accurately guide lesion placement in the canine right atrium.
Methods
Nine adult mongrel dogs (Canis familiaris) weighing 26.5+±5.2 kg were premedicated with Innovar-vet (0.1 mL/kg SC) and anesthetized with sodium pentobarbital (7 to 15 mg/kg IV). After intubation, the dogs were mechanically ventilated, and the ECG and anesthetic tone were continuously monitored. Venous access was obtained with 8F and 1OF sheaths by femoral cut-down technique. All studies conformed to the "Position of the American Heart Association on Research Animal Use" adopted November 11, 1984 , and the University of California, Committee on Animal Research, in an approved protocol.
The Intracardiac Echocardiographic System
The imaging system comprised a 10-MHz ultrasound transducer mounted on the tip of a 10F, 120-cm-long, over-the-wire catheter (CVIS, Cardiovascular Imaging Systems, Sunnyvale, Calif). The outer diameter of the catheter was 0.131 in (0.333 cm), which is passed through a 1OF intravascular sheath with an internal diameter of 0.136 in (0.345 cm). At a focal depth of 4 cm, the axial resolution is 450 ,um and the lateral resolution is 750 ,um. The imaging plane is orthogonal to the catheter, with a radial field of view of 4 cm. Images are acquired at 28 frames per second and recorded on a 0.5-in (1.27 cm) super VHS videotape for review. For comparisons at different times during the procedure, images were selected with the same anatomic landmarks and at the point during the cardiac cycle of maximum chamber volume. 
Catheter Ablation and Imaging Procedures
The intracardiac imaging catheter was placed into the right atrium, without fluoroscopic guidance, and continuous imaging was performed. A 7F, tip-defecting catheter (EP Technologies, Mountain View, Calif) with an 8F, 4-or 5-mm electrode tip then was placed in the right atrium under fluoroscopic guidance. Further catheter manipulations were guided with ICE. In the interest of safety, with the first three study animals, standard fluoroscopic confirmation of catheter tip position was performed after ICE guidance. In the subsequent studies, the catheter position did not require fluoroscopic confirmation. Fluoroscopic exposure times were logged.
RF energy was applied to spatially disparate anatomic landmarks that were identified by ICE: (1) the junction of the superior vena cava (SVC) with the right atrium (RA), (2) the junction of the inferior vena cava (IVC) and the RA, (3) the fossa ovalis, (4) the coronary sinus ostium, and (5) the orifice of the RA appendage (identified by visualization of pectinate muscles). Gentle manipulation of the imaging catheter was required to identify the ablation tip, which was echoreflective and had a characteristic fan-shaped acoustic shadow (Fig 1) . RF energy (500 kHz) was applied between the distal electrode and a large surface area skin patch, with a mean RF power of 43+ 17 W for 60 seconds.
Ultrasound Pathological Correlation
After intravenous injection of a myocardial histochemical stain, triphenyl-tetrazolium chloride, the dogs were euthanized with high-dose sodium pentobarbital (200 mg/kg IV) followed by bolus potassium concentrate (20 mL IV). The heart and proximal great vessels were immediately removed. Results High-resolution images were obtained in all studies, although during the RF energy application, background artifact was seen to slightly degrade image quality. The following major anatomic landmarks of the RA were identified in every animal: the SVC, the orifice of the RA appendage, the fossa ovalis of the interatrial septum, the coronary sinus ostium, the tricuspid valve, the eustachian valve, and the IVC. The imaging catheter did not interfere with the maneuverability of the ablation catheter. No arrhythmias or hemodynamic changes were observed during the procedure, and there was no damage to cardiac structures on pathological examination.
ICE Targeting of Catheter Ablation
Under ICE guidance, RF energy was applied to four sites in seven dogs and five sites in two, for a total of 38 applications. Thirty-eight lesions were identified on pathological examination and were sharply demarcated from viable myocardium, which was stained deep red (Fig 2) . The mean lesion volume was 56±63 mm3.
The measured error between the center of the predicted ICE target and the lesion identified on pathological examination was 1.9±2.1 mm to the lesion center and 0.7± 1.3 mm to the lesion edge (Fig 3) . The (IVC) , to the right, and through the right ventricular free wall, exposing the right atrium, the septal leaflet of the tricuspid valve (TV), and the right ventricle (RV), both to the upper right. Lesions were targeted and can be identified at the SVC-right atrial junction (1) , the posterior lip of the coronary sinus (CS) ostium (2), the fossa ovalis (3) , and the posterolateral IVC-right atrial junction (not seen).
In Vivo Observations
We recorded endocardial-catheter tip continuity in 37 of 38 (97%) RF energy applications. During videotape review, the ablation catheter shaft was misidentified as the distal electrode in one application. In nine applications (24%), the catheter was observed to move during RF energy application, occurring with the respiratory and the cardiac cycles. This movement was frequently of the order of 2 to 4 mm and was usually manifest as sliding of the electrode without loss of endocardial contact. These lesions did not have significantly different morphology or lesion volume (66+67 mm3) compared with applications without observed movement (53±63 mm3).
Discrete lesions were clearly identified in 13 of 38 (34%) RF energy applications and could be seen as a defect or dimple in the endocardial continuity not present before RF application (Fig 4) . The tissue beneath these lesions appeared to have an increased echodensity.
Microcavitations or bubbles were seen during 23 (61%) RF energy applications and frequently occurred in a cyclic manner, in phase with respiratory motion. Movement of the catheter was associated with bubbles in seven of nine (77%) applications. Thrombus could be identified in 19 applications (50%), typically remaining adherent to the lesion edge after removal of the catheter (Fig 5) . In all cases of thrombus formation, microcavitations were present during the energy application, but an impedence rise causing automatic RF energy shutdown did not occur.
Fluoroscopy
The fluoroscopic exposure time was 23 minutes for the first case, 4 and 3 minutes for the next two cases, and less than 2 minutes for each of the last five cases.
Discussion
At present, catheter ablation requires fluoroscopy for the manipulation and placement of the ablation electrode, which is associated with significant radiation exposure. 4 Previous studies have examined the role of echocardiography in guiding ablation procedures. However, localization by transthoracic echocardiography is limited by catheter shaft artifact and proper identification of the catheter tip.8 In an animal model, a transponder catheter system using transthoracic echocardiographic guidance demonstrated precise localization of an electrode catheter,9 but this technique has not been performed in humans. Transesophageal echocardiography has been used to assist in the positioning of catheters and to monitor for complica- 
